MON-LB002 Diabetes Care Network: A Telehealth Based Collaborative Approach to Scale Endocrine Expertise

Background: Diabetes Care Network (DCN) is a collaborative care pathway that uses a team approach via telehealth to modernize diabetes care delivery and scale the endocrine expertise for complex diabetic patients. Methods: We studied the efficacy and sustainability of our approach to improving diabe...

Descripción completa

Detalles Bibliográficos
Autores principales: Bandi, Archana, Larson, Meg, Beattie, Janice, Summerville, Ashley, Lumley, Brandi, Lutz-McCain, Stacey, B-Kelly, Monique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550751/
http://dx.doi.org/10.1210/js.2019-MON-LB002
_version_ 1783424253435052032
author Bandi, Archana
Larson, Meg
Beattie, Janice
Summerville, Ashley
Lumley, Brandi
Lutz-McCain, Stacey
B-Kelly, Monique
author_facet Bandi, Archana
Larson, Meg
Beattie, Janice
Summerville, Ashley
Lumley, Brandi
Lutz-McCain, Stacey
B-Kelly, Monique
author_sort Bandi, Archana
collection PubMed
description Background: Diabetes Care Network (DCN) is a collaborative care pathway that uses a team approach via telehealth to modernize diabetes care delivery and scale the endocrine expertise for complex diabetic patients. Methods: We studied the efficacy and sustainability of our approach to improving diabetes care over 12 months among 101 Veterans with poorly controlled Type 2 Diabetes (T2DM) (A1c>9%) identified from the electronic database. Among all enrolled Veterans, 87 (86.1%) were followed for 12 months. We assessed consultation completion via E-consult and protocol-based continuity care collaboration with primary care liaisons. Means (SD), frequencies, and percentages are presented, and Spearman correlations were assessed. Statistical significance set at p<0.05. Results: The cohort (N=87) was 97.7% male, 90.8% white, had a mean age 67.2 (8.9), and an average of 3.3 comorbidities, 0.7 macro-, and 1.3 microvascular complications. Initial care delivered via E-consult within 2.6(1.7) days with weekly follow-up telephonic team meetings. Collaborative care in the study cohort (N=87) allowed for therapy optimization and/or escalation with the initiation of metformin in 9 (10.3%), SGLT-2-I in 6 (6.8%), DPP-4I in 8 (9.1%), insulin U500 in 8 (9.1%), GLP-1A agents in 25 (28.7%), any insulin in 12 (13.7%), discontinuation of metformin in 9 (10.3%) and oral sulfonylurea in 17 (19.5%) Veterans. Of the 24 (27%) non-insulin users at enrollment, 12 Veterans initiated insulin therapy by 12 months. A1C declined significantly from the baseline A1C of 10.2% (1.4), to 8.1% (0.99) at 3 months, 7.6% (0.96) at 6 months, and 7.5 % (0.86) at 12 months (all p<.0001). At 3, 6, 12 months, number of patients who achieved HBA1c <8 % were 38 (43.6%), 56 (64%), and 56 (64%), and number of patients who achieved HBA1c <7% were 10 (11.4%), 21 (24.1%), and 23 (26.4%), respectively. Non-statistically significant improvements were noted in Weight {229.3lbs (48.1) to 228.4lbs (46.9)}, LDL {89.0mg/dl (36.4) to 79.5mg/dl (32.5)}, systolic BP {130.5mmHg (16.1) to 123.9mmHg (17.5)}, and triglycerides {226.9 mg/dl (195.3) to 159.3 (97.4)}. Compared to the 12 months pre-enrollment period, no difference in healthcare utilization (ER visits or admissions) was noted in the post-enrollment period. From baseline to completion, only nonsignificant improvements were noted in secondary preventative therapy for the use of antiplatelet agents, ACE-I/ARB, moderate to high-intensity statins and, the frequency of urine microalbumin tests, and annual foot/ retinal exams. Conclusions: With the DCN approach, we show that using telehealth technologies and collaborative partnerships, endocrine expertise can successfully be scaled to address the shortage of endocrinologists and help attain improved diabetes control. Such pathways will alleviate the large burden on primary care and address primary care inertia with timely therapy optimizations. Unless otherwise noted, all abstracts presented at ENDO are embargoed until the date and time of presentation. For oral presentations, the abstracts are embargoed until the session begins. Abstracts presented at a news conference are embargoed until the date and time of the news conference. The Endocrine Society reserves the right to lift the embargo on specific abstracts that are selected for promotion prior to or during ENDO.
format Online
Article
Text
id pubmed-6550751
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-65507512019-06-13 MON-LB002 Diabetes Care Network: A Telehealth Based Collaborative Approach to Scale Endocrine Expertise Bandi, Archana Larson, Meg Beattie, Janice Summerville, Ashley Lumley, Brandi Lutz-McCain, Stacey B-Kelly, Monique J Endocr Soc Healthcare Delivery and Education Background: Diabetes Care Network (DCN) is a collaborative care pathway that uses a team approach via telehealth to modernize diabetes care delivery and scale the endocrine expertise for complex diabetic patients. Methods: We studied the efficacy and sustainability of our approach to improving diabetes care over 12 months among 101 Veterans with poorly controlled Type 2 Diabetes (T2DM) (A1c>9%) identified from the electronic database. Among all enrolled Veterans, 87 (86.1%) were followed for 12 months. We assessed consultation completion via E-consult and protocol-based continuity care collaboration with primary care liaisons. Means (SD), frequencies, and percentages are presented, and Spearman correlations were assessed. Statistical significance set at p<0.05. Results: The cohort (N=87) was 97.7% male, 90.8% white, had a mean age 67.2 (8.9), and an average of 3.3 comorbidities, 0.7 macro-, and 1.3 microvascular complications. Initial care delivered via E-consult within 2.6(1.7) days with weekly follow-up telephonic team meetings. Collaborative care in the study cohort (N=87) allowed for therapy optimization and/or escalation with the initiation of metformin in 9 (10.3%), SGLT-2-I in 6 (6.8%), DPP-4I in 8 (9.1%), insulin U500 in 8 (9.1%), GLP-1A agents in 25 (28.7%), any insulin in 12 (13.7%), discontinuation of metformin in 9 (10.3%) and oral sulfonylurea in 17 (19.5%) Veterans. Of the 24 (27%) non-insulin users at enrollment, 12 Veterans initiated insulin therapy by 12 months. A1C declined significantly from the baseline A1C of 10.2% (1.4), to 8.1% (0.99) at 3 months, 7.6% (0.96) at 6 months, and 7.5 % (0.86) at 12 months (all p<.0001). At 3, 6, 12 months, number of patients who achieved HBA1c <8 % were 38 (43.6%), 56 (64%), and 56 (64%), and number of patients who achieved HBA1c <7% were 10 (11.4%), 21 (24.1%), and 23 (26.4%), respectively. Non-statistically significant improvements were noted in Weight {229.3lbs (48.1) to 228.4lbs (46.9)}, LDL {89.0mg/dl (36.4) to 79.5mg/dl (32.5)}, systolic BP {130.5mmHg (16.1) to 123.9mmHg (17.5)}, and triglycerides {226.9 mg/dl (195.3) to 159.3 (97.4)}. Compared to the 12 months pre-enrollment period, no difference in healthcare utilization (ER visits or admissions) was noted in the post-enrollment period. From baseline to completion, only nonsignificant improvements were noted in secondary preventative therapy for the use of antiplatelet agents, ACE-I/ARB, moderate to high-intensity statins and, the frequency of urine microalbumin tests, and annual foot/ retinal exams. Conclusions: With the DCN approach, we show that using telehealth technologies and collaborative partnerships, endocrine expertise can successfully be scaled to address the shortage of endocrinologists and help attain improved diabetes control. Such pathways will alleviate the large burden on primary care and address primary care inertia with timely therapy optimizations. Unless otherwise noted, all abstracts presented at ENDO are embargoed until the date and time of presentation. For oral presentations, the abstracts are embargoed until the session begins. Abstracts presented at a news conference are embargoed until the date and time of the news conference. The Endocrine Society reserves the right to lift the embargo on specific abstracts that are selected for promotion prior to or during ENDO. Endocrine Society 2019-04-30 /pmc/articles/PMC6550751/ http://dx.doi.org/10.1210/js.2019-MON-LB002 Text en Copyright © 2019 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Healthcare Delivery and Education
Bandi, Archana
Larson, Meg
Beattie, Janice
Summerville, Ashley
Lumley, Brandi
Lutz-McCain, Stacey
B-Kelly, Monique
MON-LB002 Diabetes Care Network: A Telehealth Based Collaborative Approach to Scale Endocrine Expertise
title MON-LB002 Diabetes Care Network: A Telehealth Based Collaborative Approach to Scale Endocrine Expertise
title_full MON-LB002 Diabetes Care Network: A Telehealth Based Collaborative Approach to Scale Endocrine Expertise
title_fullStr MON-LB002 Diabetes Care Network: A Telehealth Based Collaborative Approach to Scale Endocrine Expertise
title_full_unstemmed MON-LB002 Diabetes Care Network: A Telehealth Based Collaborative Approach to Scale Endocrine Expertise
title_short MON-LB002 Diabetes Care Network: A Telehealth Based Collaborative Approach to Scale Endocrine Expertise
title_sort mon-lb002 diabetes care network: a telehealth based collaborative approach to scale endocrine expertise
topic Healthcare Delivery and Education
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550751/
http://dx.doi.org/10.1210/js.2019-MON-LB002
work_keys_str_mv AT bandiarchana monlb002diabetescarenetworkatelehealthbasedcollaborativeapproachtoscaleendocrineexpertise
AT larsonmeg monlb002diabetescarenetworkatelehealthbasedcollaborativeapproachtoscaleendocrineexpertise
AT beattiejanice monlb002diabetescarenetworkatelehealthbasedcollaborativeapproachtoscaleendocrineexpertise
AT summervilleashley monlb002diabetescarenetworkatelehealthbasedcollaborativeapproachtoscaleendocrineexpertise
AT lumleybrandi monlb002diabetescarenetworkatelehealthbasedcollaborativeapproachtoscaleendocrineexpertise
AT lutzmccainstacey monlb002diabetescarenetworkatelehealthbasedcollaborativeapproachtoscaleendocrineexpertise
AT bkellymonique monlb002diabetescarenetworkatelehealthbasedcollaborativeapproachtoscaleendocrineexpertise